
Vivera Pharmaceuticals, Inc., EFT Global Holdings, Inc. d/b/a Sentar Pharmaceuticals, and Paul P. Edalat
Sep 30, 2022
SEC Charges Vivera Pharmaceuticals and Its CEO with Offering Fraud
Read the full report at Read More
Sep 30, 2022
SEC Charges Vivera Pharmaceuticals and Its CEO with Offering Fraud
Read the full report at Read More